Longitudinal Pancreatic Cancer Study

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Pancreatic Cancer
Interventions
OTHER

CA 19-9 Assay

Physicians use the CA 19-9 test results to manage their patients

Trial Locations (7)

21237

Harry & Jeanette Weinberg Cancer Institute, Baltimore

28402

New Hanover Regional Medical Center, Wilmington

33316

Broward Health Medical Center, Fort Lauderdale

33486

Boca Raton Regional Hospital, Boca Raton

43210

The Ohio State University, Columbus

64128

Kansas City VA Center, Kansas City

V6Z2K5

GI Research Institute, Vancouver

Sponsors
All Listed Sponsors
lead

Fujirebio Diagnostics, Inc.

INDUSTRY